Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Olaye

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Orphanet Journal of Rare Diseases|August 29, 2023
A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcelNigel Armstrong, Andrew Olaye, Caro Noake, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Economic Modeling Considerations for Rare DiseasesIsobel Pearson, Ben Rothwell, Andrew Olaye, et al.
Advanced Drug Delivery Reviews|June 2, 2007
Polymer carriers for drug delivery in tissue engineeringMarina Sokolsky-Papkov, Kapil Agashi, Andrew Olaye, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 8, 2021
Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]Domenico Moro, Michael Schlander, Harry Telser, et al.
International Journal of Neonatal Screening|July 25, 2024
Exploring the Cost-Effectiveness of Newborn Screening for Metachromatic Leukodystrophy (MLD) in the UKKaren Bean, Simon A Jones, Anupam Chakrapani, et al.
Plos One|May 22, 2024
Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial dataNicola Specchio, Paul Gissen, Emily de Los Reyes, et al.
Orphanet Journal of Rare Diseases|November 19, 2014
A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseasesRegina M Leadley, Shona Lang, Kate Misso, et al.
Orphanet Journal of Rare Diseases|May 13, 2021
Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)Paul Gissen, Nicola Specchio, Andrew Olaye, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Orphanet Journal of Rare Diseases|August 29, 2023
A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcelNigel Armstrong, Andrew Olaye, Caro Noake, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Economic Modeling Considerations for Rare DiseasesIsobel Pearson, Ben Rothwell, Andrew Olaye, et al.
Advanced Drug Delivery Reviews|June 2, 2007
Polymer carriers for drug delivery in tissue engineeringMarina Sokolsky-Papkov, Kapil Agashi, Andrew Olaye, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 8, 2021
Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]Domenico Moro, Michael Schlander, Harry Telser, et al.
International Journal of Neonatal Screening|July 25, 2024
Exploring the Cost-Effectiveness of Newborn Screening for Metachromatic Leukodystrophy (MLD) in the UKKaren Bean, Simon A Jones, Anupam Chakrapani, et al.
Plos One|May 22, 2024
Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial dataNicola Specchio, Paul Gissen, Emily de Los Reyes, et al.
Orphanet Journal of Rare Diseases|November 19, 2014
A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseasesRegina M Leadley, Shona Lang, Kate Misso, et al.
Orphanet Journal of Rare Diseases|May 13, 2021
Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)Paul Gissen, Nicola Specchio, Andrew Olaye, et al.
Pageof 1